123I-metaiodobenzylguanidine (MIBG) Scintigraphy for the Detection of Adrenal and Extra-adrenal Phaeochromocytomas: CT and MRI Correlation
Overview
Authors
Affiliations
Context: Evidence regarding the accuracy of [(123)I] metaiodobenzylguanidine (MIBG) imaging for phaeochromocytoma localization is currently limited to small series.
Objective: We present the largest series of primary phaeochromocytomas in which the performance of [(123)I]MIBG has been evaluated and correlated with cross-sectional imaging.
Design: We identified 76 patients with both preoperative [(123)I]MIBG and cross-sectional imaging for confirmed primary phaeochromocytoma between 1995 and 2005 at our institution. This comprised 60 adrenal tumours in 55 patients and 33 extra-adrenal tumours in 23 patients (2 patients had both adrenal and extra-adrenal tumours). Phaeochromocytoma metastases were not evaluated.
Main Outcome Measure(s): [(123)I]MIBG studies were independently reviewed and correlated with CT and MRI examinations, as well as tumour functional status, to identify features that may predict a false negative [(123)I]MIBG result.
Results: The overall sensitivity of [(123)I]MIBG was 75%. Tumour detection was lower for extra-adrenal (58%) vs. adrenal (85%) phaeochromocytomas (P = 0.005). For extra-adrenal tumours, [(123)I]MIBG demonstrated 8 of 14 carotid body, 2 of 2 intrathoracic, 8 of 14 retroperitoneal and 2 of 3 pelvic phaeochromocytomas. Overall, MRI and CT demonstrated 68 of 68 and 72 of 74 primary phaeochromocytomas, respectively. Tumour size correlated with [(123)I]MIBG uptake for adrenal (P = 0.009) but not extra-adrenal tumours. When tumours were adjusted for size, no other imaging feature or functional status correlated with [(123)I]MIBG negativity, although two large [(123)I]MIBG negative adrenal tumours contained large areas of necrosis or haemorrhage.
Conclusions: Extra-adrenal and small adrenal phaeochromocytomas are more likely to result in false negatives on [(123)I]MIBG. Tumoural necrosis or haemorrhage do not consistently relate to [(123)I]MIBG uptake, although adrenal phaeochromocytomas containing minimal solid tissue due to extensive necrosis may predict a negative [(123)I]MIBG result.
Yokoyama K, Matsuki M, Isozaki T, Ito K, Imokawa T, Ozawa A Jpn J Radiol. 2025; .
PMID: 39794659 DOI: 10.1007/s11604-025-01732-6.
Pheochromocytoma: an updated scoping review from clinical presentation to management and treatment.
Saavedra T J, Nati-Castillo H, Valderrama Cometa L, Rivera-Martinez W, Asprilla J, Castano-Giraldo C Front Endocrinol (Lausanne). 2024; 15:1433582.
PMID: 39735644 PMC: 11671257. DOI: 10.3389/fendo.2024.1433582.
Kawanabe S, Katabami T, Oshima R, Yanagisawa N, Sone M, Kimura N Front Endocrinol (Lausanne). 2023; 13:1054468.
PMID: 36704041 PMC: 9871575. DOI: 10.3389/fendo.2022.1054468.
Hereditary Pheochromocytoma With a Mutation in the Succinate Dehydrogenase Subunit A Gene.
Karuppasamy G, Farooqi A, Sajid S, Elouzi E Cureus. 2022; 14(4):e24584.
PMID: 35664384 PMC: 9148421. DOI: 10.7759/cureus.24584.
Imaging incidental adrenal lesions.
Sahdev A Br J Radiol. 2022; 96(1142):20220281.
PMID: 35543634 PMC: 9975514. DOI: 10.1259/bjr.20220281.